Table of Contents
Pradaxa (Atrial Fibrillation) - Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Pradaxa (Atrial Fibrillation) - Analysis and Forecasts to 2022” provides Pradaxa global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2011-2022). ...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Alison
(866) 682 9815
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...
Actonel (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Actonel (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
REPORT SCOPE INTRODUCTION REASONS FOR DOING THE STUDY The spread of human immunodeficiency virus (HIV), hepatitis B and C, evolving influenza strains and antibiotic-resistant organisms have put healthcare ...
... Guidelines say People with diabetes and hypertension should be treated to a systolic blood pressure goal of 140 mmhg. Lower systolic targets (such as ...
... Outcomes and reduce resistance rates Decreased number of antimicrobial drugs in pipeline from Antimicrobial stewardship, Jamie winner. Management of infectious diseases 32nd annual madison clinical ...
... To target chronic pain market with a novel opioid: Slow rate of entry into cns designed to: Reduce abuse liability Reduce drowsiness Reduce respiratory depression Long-acting profile Properties ...
Reportlinker.com © Copyright 2013. All rights reserved.